CancerPath
Cancer is hard enough. Understanding it shouldn't be.
- Business Model
- B2B
- Website
- mycancerpath.com
- Total Funding
- $150K
- Last Round
- $150K SeedJan 2023
About
MyCancerPath (CancerPath) connects cancer patients and their families with Precision Medicine Navigators — PhD-trained scientists who help patients understand their diagnosis, interpret biomarker and genomic test results, map treatment options against current evidence, and prepare for medical discussions. The service addresses a critical gap in cancer care: 60% of cancer patients do not receive complete biomarker testing and fewer than 37% receive optimal treatment even when eligible. CancerPath is not a medical provider but a knowledge and navigation layer that works alongside a patient's existing care team to ensure scientific completeness and informed decision-making throughout the cancer journey.
Summary
CancerPath is a Healthcare company. It has raised $150K in total, most recently a $150K Seed round in Jan 2023.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Hyland provides content services and intelligent automation solutions for enterprises.
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...